01 3HARROW EYE
02 4MYLAN SPECIALITY LP
01 17559325
02 17795316
03 18101582
04 18450287
05 18664187
06 18869794
07 110207066
01 7Blank
01 6Y
02 1Blank
01 12025-06-20
02 12025-10-27
03 22027-12-19
04 12028-08-03
05 12028-09-12
06 12030-11-04
Patent Expiration Date : 2028-08-03
US Patent Number : 7795316
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 50818
Patent Use Code : U-1082
Delist Requested :
Patent Use Description : USE OF A COMBINATION O...
Patent Expiration Date : 2028-08-03
Patent Expiration Date : 2027-12-19
US Patent Number : 8101582
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 50818
Patent Use Code : U-1082
Delist Requested :
Patent Use Description : USE OF A COMBINATION O...
Patent Expiration Date : 2027-12-19
Patent Expiration Date : 2027-12-19
US Patent Number : 8450287
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 50818
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-12-19
Patent Expiration Date : 2025-06-20
US Patent Number : 8664187
Drug Substance Claim :
Drug Product Claim :
Application Number : 201688
Patent Use Code : U-909
Delist Requested :
Patent Use Description : TREATMENT OF CYSTIC FI...
Patent Expiration Date : 2025-06-20
Patent Expiration Date : 2028-09-12
US Patent Number : 8869794
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 201688
Patent Use Code : U-909
Delist Requested :
Patent Use Description : TREATMENT OF CYSTIC FI...
Patent Expiration Date : 2028-09-12
Patent Expiration Date : 2030-11-04
US Patent Number : 10207066
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 201688
Patent Use Code : U-909
Delist Requested :
Patent Use Description : TREATMENT OF CYSTIC FI...
Patent Expiration Date : 2030-11-04
Patent Expiration Date : 2025-10-27
US Patent Number : 7559325
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 201688
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-10-27
